Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02476851 · ClinicalTrials.gov registry record · NA
Clinical Investigation to Evaluate the Haemonetics POLFA Modified Sample Needle Assembly With Vacuum Tube Holder
A NA study, sponsored by Haemonetics Corporation.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT02476851 is a NA study that has completed, run by Haemonetics Corporation. The registered enrollment target is 62 participants.
The verdict
NCT02476851, a NA study, has completed, sponsored by Haemonetics Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
This study evaluates whether whole blood transferred through the new POLFA needle assembly meets supernatant hemoglobin acceptability standards.
Interventions
- DEVICE POLFA (Needle Assembly)
- DEVICE Kawasumi (Needle Assembly)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2015-06 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02476851
The ClinicalTrials.gov registry entry for NCT02476851 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Haemonetics Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which POLFA (Needle Assembly) is the first listed.
NCT02476851 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02476851 about?
NCT02476851 is a clinical study titled "Clinical Investigation to Evaluate the Haemonetics POLFA Modified Sample Needle Assembly With Vacuum Tube Holder". This study evaluates whether whole blood transferred through the new POLFA needle assembly meets supernatant hemoglobin acceptability standards.
What is the current status of trial NCT02476851?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2015-06. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02476851?
The interventions under investigation include: POLFA (Needle Assembly) (DEVICE), Kawasumi (Needle Assembly) (DEVICE).
Who is sponsoring clinical trial NCT02476851?
This trial is sponsored by Haemonetics Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.